+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurovascular Embolization Devices Market Size, Share & Trends Analysis Report By Product (Embolic Coils, Flow Diversion Devices), By End-use (Hospitals, Specialty Clinics), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 110 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899602
Description Jump to:
The global neurovascular embolization devices market size is anticipated to reach USD 1.76 billion by 2030, registering a CAGR of 6.60% from 2023 to 2030. Increased stroke incidence, growth in demand for minimally invasive procedures, mergers and partnerships among the industry key players drives the market growth. The market is growing rapidly in developing nations with expanding disposable incomes and improved access to healthcare. Device manufacturers have new opportunities for growth as a result of this which is anticipated to expand the market globally.

The rising prevalence of stroke around the world is the main factor driving the growth of the market. Stroke is one of the main causes of disability and death, and as the world's population ages, risk factors for stroke, like diabetes and high blood pressure, are more common. The need for neurovascular embolization tools used in the treatment and prevention of strokes has increased as an outcome of this. Over the course of the projected period, it is anticipated that the prevalence of brain aneurysms and strokes will fuel global market expansion.

For instance, the World Stroke Organization predicted that by 2022, the prevalence of strokes already reached epidemic levels. Over 12.2 million people worldwide were estimated to experience a stroke for the first time this year, and 6.5 million deaths were projected as a result, with 1 out of every 4 adults over the age of 25 expected to suffer a stroke in their lifetime.

The effectiveness and safety of therapies have increased due to ongoing developments in neurovascular embolization technology. Leading medical device companies are expanding their product lines in the neurovascular industry, increasing rivalry and fostering innovation. The key industry players are involved in product manufacturing and development for the advancements in the neurovascular embolization sectors which boosts the industry growth. For instance, in February 2023, the German EMBO-Post Market Surveillance Registry's first patient was treated by Shape Memory Medical. Peripheral vascular embolization was carried out using the IMPEDE and IMPEDE-FX embolization plugs from the company's perspective, multicenter registry research.

Neurovascular Embolization Devices Market Highlights
-In 2022, the embolic coils segment dominated with a market share of 77.66%. The embolic coils market has steadily expanded over the years as a result of rising awareness, bettering treatment methods, and developments in coil technology
-Among end-use, hospitals held a majority share of the market of 71.87% in 2022. The use of neurovascular embolization devices is one of the treatment choices that hospitals educate patients and their families about when it comes to neurovascular diseases. As hospitals continue to improve their capabilities and adopt the latest medical technologies, the demand for these devices is expected to remain strong
-North America dominated the market with a share of 26.44% in 2022. The market is competitive, with both established companies and emerging players striving to capture market share through product innovation, mergers, acquisitions, and partnerships. Thus, the presence of the key players in this region enhances the industry's growth

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Neurovascular Embolization Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of neurovascular disorders
3.4.1.2. Technological advancements
3.4.1.3. Improved disease diagnostic techniques
3.4.2. Market restraint analysis
3.4.2.1. High cost of devices
3.5. Neurovascular Embolization Devices Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Neurovascular Embolization Devices Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Embolic Coils
4.1.2. Flow Diversion Devices
4.1.3. Liquid Embolic Agents
4.1.4. Aneurysm Clips
4.2. Product Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Neurovascular Embolization Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Embolic Coils
4.5.1.1. Embolic coils market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Flow Diversion Devices
4.5.2.1. Flow diversion devices market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Liquid Embolic Agents
4.5.3.1. Liquid embolic agents market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Aneurysm Clips
4.5.4.1. Aneurysm clips market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Neurovascular Embolization Devices Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Specialty Clinics
5.1.3. Others
5.2. End-use Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Neurovascular Embolization Devices Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Specialty Clinics
5.5.2.1. Specialty clinics market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Neurovascular Embolization Devices Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2022
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030
6.6. North America
6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. UK market estimates and forecasts, 2018 - 2030
6.7.2. Germany
6.7.2.1. Key country dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 - 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive Scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
6.8.2. India
6.8.2.1. Key country dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. India market estimates and forecasts, 2018 - 2030
6.8.3. China
6.8.3.1. Key country dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. China market estimates and forecasts, 2018 - 2030
6.8.4. South Korea
6.8.4.1. Key country dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
6.8.5. Australia
6.8.5.1. Key country dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive Scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive Scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive Scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive Scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive Scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Competitive Scenario
6.10.4.3. Regulatory framework
6.10.4.4. Reimbursement scenario
6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2022
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Stryker
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. MicroVention Inc.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Cerenovus
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Integra LifeSciences
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Penumbra, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Balt SAS
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. B. Braun Melsungen AG
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Phenox GmbH
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
List of Tables
Table 1. List of Secondary Sources
Table 2. List of Abbreviations
Table 3. Global neurovascular embolization devices market, by region 2018-2030 (USD Million)
Table 4. Global neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 5. Global neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 6. North America neurovascular embolization devices market, by country, 2018-2030 (USD Million)
Table 7. North America neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 8. North America neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 9. U.S. neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 10. U.S. neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 11. Canada neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 12. Canada neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 13. Europe neurovascular embolization devices market, by country, 2018-2030 (USD Million)
Table 14. Europe neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 15. Europe neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 16. UK neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 17. UK neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 18. Germany neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 19. Germany neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 20. France neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 21. France neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 22. Italy neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 23. Italy neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 24. Spain neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 25. Spain neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 26. Denmark neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 27. Denmark neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 28. Sweden neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 29. Sweden neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 30. Norway neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 31. Norway neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 32. Asia Pacific neurovascular embolization devices market, by country, 2018-2030 (USD Million)
Table 33. Asia Pacific neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 34. Asia Pacific neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 35. Japan neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 36. Japan neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 37. China neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 38. China neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 39. India neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 40. India neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 41. Australia neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 42. Australia neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 43. Thailand neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 44. Thailand neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 45. South Korea neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 46. South Korea neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 47. Latin America neurovascular embolization devices market, by country, 2018-2030 (USD Million)
Table 48. Latin America neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 49. Latin America neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 50. Brazil neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 51. Brazil neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 52. Mexico neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 53. Mexico neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 54. Argentina neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 55. Argentina neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 56. MEA neurovascular embolization devices market, by country, 2018-2030 (USD Million)
Table 57. MEA neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 58. MEA neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 59. South Africa neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 60. South Africa neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 61. Saudi Arabia neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 62. Saudi Arabia neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 63. UAE neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 64. UAE neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
Table 65. Kuwait neurovascular embolization devices market, by product, 2018-2030 (USD Million)
Table 66. Kuwait neurovascular embolization devices market, by end-use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Neurovascular embolization devices market: Market snapshot
Fig. 9 Neurovascular embolization devices market: Market segmentation
Fig. 10 Neurovascular embolization devices market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Neurovascular embolization devices market driver impact
Fig. 14 Neurovascular embolization devices market restraint impact
Fig. 15 Neurovascular embolization devices market porter’s five forces analysis
Fig. 16 Neurovascular embolization devices market PESTEL analysis
Fig. 17 Neurovascular embolization devices market segment dashboard
Fig. 18 Neurovascular embolization devices market: Product movement Analysis
Fig. 19 Embolic coils market estimates and forecast, 2018-2030 (USD Million)
Fig. 20 Flow diversion devices market estimates and forecast, 2018-2030 (USD Million)
Fig. 21 Liquid embolic agents market estimates and forecast, 2018-2030 (USD Million)
Fig. 22 Aneurysm clips market estimates and forecast, 2018-2030 (USD Million)
Fig. 23 Neurovascular embolization devices market segment dashboard
Fig. 24 Neurovascular embolization devices market: End-use movement Analysis
Fig. 25 Hospitals market estimates and forecast, 2018-2030 (USD Million)
Fig. 26 Specialty clinics market estimates and forecast, 2018-2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018-2030 (USD Million)
Fig. 28 Global neurovascular embolization devices market: Regional movement analysis
Fig. 29 Global neurovascular embolization devices market: Regional outlook and key takeaways
Fig. 30 Global market share, by region
Fig. 31 North America market estimates and forecast, 2018-2030 (USD Million)
Fig. 32 U.S. market estimates and forecast, 2018-2030 (USD Million)
Fig. 33 Canada market estimates and forecast, 2018-2030 (USD Million)
Fig. 34 Europe market estimates and forecast, 2018-2030 (USD Million)
Fig. 35 UK market estimates and forecast, 2018-2030 (USD Million)
Fig. 36 Germany market estimates and forecast, 2018-2030 (USD Million)
Fig. 37 France market estimates and forecast, 2018-2030 (USD Million)
Fig. 38 Italy market estimates and forecast, 2018-2030 (USD Million)
Fig. 39 Spain market estimates and forecast, 2018-2030 (USD Million)
Fig. 40 Denmark market estimates and forecast, 2018-2030 (USD Million)
Fig. 41 Sweden market estimates and forecast, 2018-2030 (USD Million)
Fig. 42 Norway market estimates and forecast, 2018-2030 (USD Million)
Fig. 43 Asia Pacific market estimates and forecast, 2018-2030 (USD Million)
Fig. 44 Japan market estimates and forecast, 2018-2030 (USD Million)
Fig. 45 China market estimates and forecast, 2018-2030 (USD Million)
Fig. 46 India market estimates and forecast, 2018-2030 (USD Million)
Fig. 47 Australia market estimates and forecast, 2018-2030 (USD Million)
Fig. 48 Thailand market estimates and forecast, 2018-2030 (USD Million)
Fig. 49 South Korea market estimates and forecast, 2018-2030 (USD Million)
Fig. 50 Latin America market estimates and forecast, 2018-2030 (USD Million)
Fig. 51 Brazil market estimates and forecast, 2018-2030 (USD Million)
Fig. 52 Mexico market estimates and forecast, 2018-2030 (USD Million)
Fig. 53 Argentina market estimates and forecast, 2018-2030 (USD Million)
Fig. 54 Middle East and Africa. market estimates and forecast, 2018-2030 (USD Million)
Fig. 55 South Africa market estimates and forecast, 2018-2030 (USD Million)
Fig. 56 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Fig. 57 UAE market estimates and forecast, 2018-2030 (USD Million)
Fig. 58 Kuwait market estimates and forecast, 2018-2030 (USD Million)

Companies Mentioned

  • Medtronic
  • Stryker
  • MicroVention Inc.
  • Cerenovus
  • Integra LifeSciences
  • Penumbra, Inc.
  • Balt SAS
  • B. Braun Melsungen AG
  • Phenox GmbH

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages110
PublishedOctober 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 1.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.76 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Neurovascular Embolization Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Neurovascular Embolization Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Neurovascular Embolization Devices Market Opportunities and Strategies to 2033 - Product Image

Neurovascular Embolization Devices Market Opportunities and Strategies to 2033

  • Report
  • 313 Pages
  • Global
From
Neurovascular Embolization Devices Global Market Report 2024 - Product Image

Neurovascular Embolization Devices Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Neurovascular Embolization Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Neurovascular Embolization Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 167 Pages
  • Global
Neurovascular Embolization Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Neurovascular Embolization Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 128 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.